113-53-1

• 常用中文名：度硫平
• 常用英文名：(E)-Dosulepin
• CAS号：113-53-1
• 分子式：C₁₉H₂₁NS
• 分子量：295.44
• 相关类别： 信号通路 G 蛋白偶联受体/G 蛋白 5-HT受体
• 发布时间：2018-05-26 08:00:00
• 更新时间：2026-07-01 09:00:30
• Dothiepin是一种具有镇静/抗焦虑活性的抗抑郁药。多蒂平是一种抑制剂,它更喜欢去甲肾上腺素的摄取,而不是血清素的摄取。多蒂平通过抑制神经元摄取促进去甲肾上腺素能神经传递。多蒂平也是组胺H1受体的拮抗剂,没有心脏毒性。Dothiepin在心因性面部疼痛、特发性纤维肌痛综合征或类风湿性关节炎中表现出显著的镇痛活性[1]。

名称

• 中文名: 度琉平
• 英文名: dothiepin
• 中文别名: 氘3-多替平马来酸盐; 多硫平-D3马来酸盐
• 英文别名: n,n-dimethyl-3-(dibenzo(b,e)thiin-delta-sup(11(6h),gamma))-propylamin; Dosuline; N,N-Dimethyl- dibenzo[b,e]thiin-11(6H),-propylamine; Dibenzo[b,e]thiin, 1-propanamine deriv; 3-Dibenzo(b,e)thiin-11(6H)-ylidene-N,N-dimethyl-1-propamine; Propylamine, N,N-dimethyl-3-(dibenzo(b,e)thiin-delta-sup(11(6H),gamma)); Dolsulepine; Dosulepin; Prothiadene; Dibenzo[b,e]thiin-delta11(6H),gamma-propylamine, N,N-dimethyl; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepin; 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiin; Dothiin-d3 Maleate; 3-(6,11-dihydrodibenzo(b,e)thiin-11-ylidene)propyldimethylamine; (3E)-3-Dibenzo[b,E]thiin-11(6H)-ylidene-N,N-dimethyl-1-propanamine; D3-Dothiin Maleate; (3E)-3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethyl-1-propanamine; 1-Propanamine, 3-dibenzo[b,e]thiin-11(6H)-ylidene-N,N-dimethyl; DOTHIIN,3-DIBENZO[B,E] THIIN-11-(6H)-YLIDENE-N,N-DIMETHYL-PROPONAMINE; (E)-3-[Dibenzo[b,e]thiin-11(6H)-ylidene]-N,N-dimethylpropane-1-amine; Dothep; trans-dothiepin; 3-Dibenzo[b,e]thiin-11(6H)-ylidene-N,N-diMethyl; Prothiaden; 3-Dibenzo[b,e]thiin-11(6H)-ylidine-N,N-dimethyl-propanamine; 11(16H)-(3-[dimethylamino]propylidene)dibenz[b,e]thiopine; dosulin; 11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenzo<b.e>thiepin; 3-dibenzo(b,e)thiin-11(6h)-ylidene-n,n-dimethyl-1-propanamin; Prothiaden spofa; Methiaden; Dolsuline; Dothiin (cis/trans); Dothiepin; CIS,TRANS-DOTHIIN,1.0MG/MLINMETHANOL; Dosulepine; 3-Dibenzo[b,e]thiin-11(6H)-ylidene-N,N-dimethyl-1-propanamine; N,N-Dimethyldibenzo(b,e)thiin-delta-sup(11(6H),gamma)propylamine; досулепин; iz914; DOTHIIN; 3-DIBENZO[B,E] THIIN-11-(6H)-YLIDENE-N,N-DIMETHYL-PROPONAMINE; (E)-3-[Dibenzo[b,e]thiin-11(6H)-ylidene]-N,N-dimethyl-1-propanamine; EINECS 204-031-2; Doth

物化性质

• 密度: 1.1±0.1 g/cm3
• 沸点: 430.9±44.0 °C at 760 mmHg
• 熔点: 55-57ºC
• 分子式: C₁₉H₂₁NS
• 分子量: 295.44
• 闪点: 214.4±28.4 °C
• 精确质量: 295.139465
• PSA: 28.54000
• LogP: 4.34
• 外观性状: 淡黄色低熔点固体
• 蒸汽压: 0.0±1.0 mmHg at 25°C
• 折射率: 1.661
• 分子结构:

  1、 摩尔折射率：95.07

  2、 摩尔体积（cm³/mol）：257.2

  3、 等张比容（90.2K）：687.4

  4、 表面张力（dyne/cm）：50.9

  5、 极化率（10-24cm3）：37.68

生物活性

• 描述: Dothiepin是一种具有镇静/抗焦虑活性的抗抑郁药。多蒂平是一种抑制剂,它更喜欢去甲肾上腺素的摄取,而不是血清素的摄取。多蒂平通过抑制神经元摄取促进去甲肾上腺素能神经传递。多蒂平也是组胺H1受体的拮抗剂,没有心脏毒性。Dothiepin在心因性面部疼痛、特发性纤维肌痛综合征或类风湿性关节炎中表现出显著的镇痛活性[1]。
• 相关类别:
  信号通路 >> 免疫及炎症 >> 组胺受体
  研究领域 >> 神经疾病
  信号通路 >> G 蛋白偶联受体/G 蛋白 >> 5-HT受体
  信号通路 >> 神经信号通路 >> 5-HT受体
  信号通路 >> G 蛋白偶联受体/G 蛋白 >> 组胺受体
• 靶点:

  Histamine H1-receptor, Noradrenaline uptake (α1-and α2-adrenoceptors and serotonin 5HT1 and 5HT2-receptors)[1]

• 参考文献:

  [1]. Lancaster SG, et al. Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 1989 Jul;38(1):123-47.

毒性和生态

CHEMICAL IDENTIFICATION RTECS NUMBER : UI1555000 CHEMICAL NAME : Propylamine, N,N-dimethyl-3-(dibenzo(b,e)thiepin-delta-sup(11(6H), gamma))- CAS REGISTRY NUMBER : 113-53-1 LAST UPDATED : 199712 DATA ITEMS CITED : 9 MOLECULAR FORMULA : C19-H21-N-S MOLECULAR WEIGHT : 295.47 WISWESSER LINE NOTATION : T C676 BY IS JHJ BU3N1&1 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - infant DOSE/DURATION : 100 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - coma Cardiac - arrhythmias (including changes in conduction) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human - woman DOSE/DURATION : 4500 ug/kg TOXIC EFFECTS : Behavioral - changes in motor activity (specific assay) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 3214 ug/kg/12D-I TOXIC EFFECTS : Behavioral - changes in psychophysiological tests TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 2143 ug/kg/8D-I TOXIC EFFECTS : Behavioral - sleep Behavioral - hallucinations, distorted perceptions Behavioral - changes in psychophysiological tests TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 31 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 150 mg/kg SEX/DURATION : male 6 day(s) pre-mating TOXIC EFFECTS : Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) TYPE OF TEST : Cytogenetic analysis MUTATION DATA TEST SYSTEM : Rodent - mouse DOSE/DURATION : 150 mg/kg REFERENCE : ACNSAX Activitas Nervosa Superior. (Avicenum, Malostranske nam. 28, Prague 1, Czechoslovakia) V.1- 1959- Volume(issue)/page/year: 15,114,1973

安全

• 危险品运输编码: UN 3249
• 包装等级: III
• 危险类别: 6.1(b)

合成路线

1531-85-7 ~% 113-53-1

文献：WO2007/136743 A2, ; Page/Page column 20-21 ;

上下游产品

上游产品  1
1531-85-7
下游产品  1
897-15-4